How does neural monitoring help during thyroid sugery for Graves’ disease?

Le Zhou, Gianlorenzo Dionigi, Alessandro Pontin, Antonella Pino, Ettore Caruso, Che Wei Wu, Hui Sun, Ralph P. Tufano, Hoon Yub Kim

Research output: Contribution to journalArticle

Abstract

We evaluate the role of intraoperative neuromonitoring (IONM) in thyroidectomy performed for Graves’ disease (GD) with an emphasis on recurrent laryngeal nerve (RLN) management and completeness of resection. The study is a retrospective series comprising 55 thyroidectomy (control group) versus 82 procedures with intermittent IONM (I-IONM) and 72 by means of continuous IONM (C-IONM). In the control group the laryngeal nerves have been identified by visualization solely. In the I-IONM group both vagal nerve (VN) and RLN have been localized and monitored during thyroid resection. C-IONM was achieved with a vagal stimulation probe. I-IONM group had shorter operating times (P = 0.032). RLN morbidity, meaning palsy rate, was 2.7% in the C-IONM group, 3.6% in I-IONM and 5.4% in the control group (P = 0.058). The proportion of complete procedures (total or near total resections) were significantly higher using monitoring technology (P = 0.049). Persistent positive serum TBII values were found in 25 (45%), 25 (30%) and 20 (27%) patients at 12 months in the control, I-IONM and C-IONM groups respectively (P = 0,04). IONM is an effective technology in GD patients.

Original languageEnglish
Pages (from-to)6-11
Number of pages6
JournalJournal of Clinical and Translational Endocrinology
Volume15
DOIs
Publication statusPublished - 2019 Mar 1
Externally publishedYes

Fingerprint

Recurrent Laryngeal Nerve
Graves Disease
Thyroid Gland
Thyroidectomy
Control Groups
Laryngeal Nerves
Technology
Paralysis
Morbidity
Serum

Keywords

  • Graves’ disease
  • Morbidity
  • Neural monitoring
  • Recurrent laryngeal nerve
  • Thyroid surgery

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

How does neural monitoring help during thyroid sugery for Graves’ disease? / Zhou, Le; Dionigi, Gianlorenzo; Pontin, Alessandro; Pino, Antonella; Caruso, Ettore; Wu, Che Wei; Sun, Hui; Tufano, Ralph P.; Kim, Hoon Yub.

In: Journal of Clinical and Translational Endocrinology, Vol. 15, 01.03.2019, p. 6-11.

Research output: Contribution to journalArticle

Zhou, Le ; Dionigi, Gianlorenzo ; Pontin, Alessandro ; Pino, Antonella ; Caruso, Ettore ; Wu, Che Wei ; Sun, Hui ; Tufano, Ralph P. ; Kim, Hoon Yub. / How does neural monitoring help during thyroid sugery for Graves’ disease?. In: Journal of Clinical and Translational Endocrinology. 2019 ; Vol. 15. pp. 6-11.
@article{91d3b2ca7710428396b710c180b61f3c,
title = "How does neural monitoring help during thyroid sugery for Graves’ disease?",
abstract = "We evaluate the role of intraoperative neuromonitoring (IONM) in thyroidectomy performed for Graves’ disease (GD) with an emphasis on recurrent laryngeal nerve (RLN) management and completeness of resection. The study is a retrospective series comprising 55 thyroidectomy (control group) versus 82 procedures with intermittent IONM (I-IONM) and 72 by means of continuous IONM (C-IONM). In the control group the laryngeal nerves have been identified by visualization solely. In the I-IONM group both vagal nerve (VN) and RLN have been localized and monitored during thyroid resection. C-IONM was achieved with a vagal stimulation probe. I-IONM group had shorter operating times (P = 0.032). RLN morbidity, meaning palsy rate, was 2.7{\%} in the C-IONM group, 3.6{\%} in I-IONM and 5.4{\%} in the control group (P = 0.058). The proportion of complete procedures (total or near total resections) were significantly higher using monitoring technology (P = 0.049). Persistent positive serum TBII values were found in 25 (45{\%}), 25 (30{\%}) and 20 (27{\%}) patients at 12 months in the control, I-IONM and C-IONM groups respectively (P = 0,04). IONM is an effective technology in GD patients.",
keywords = "Graves’ disease, Morbidity, Neural monitoring, Recurrent laryngeal nerve, Thyroid surgery",
author = "Le Zhou and Gianlorenzo Dionigi and Alessandro Pontin and Antonella Pino and Ettore Caruso and Wu, {Che Wei} and Hui Sun and Tufano, {Ralph P.} and Kim, {Hoon Yub}",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.jcte.2018.11.002",
language = "English",
volume = "15",
pages = "6--11",
journal = "Journal of Clinical and Translational Endocrinology",
issn = "2214-6237",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - How does neural monitoring help during thyroid sugery for Graves’ disease?

AU - Zhou, Le

AU - Dionigi, Gianlorenzo

AU - Pontin, Alessandro

AU - Pino, Antonella

AU - Caruso, Ettore

AU - Wu, Che Wei

AU - Sun, Hui

AU - Tufano, Ralph P.

AU - Kim, Hoon Yub

PY - 2019/3/1

Y1 - 2019/3/1

N2 - We evaluate the role of intraoperative neuromonitoring (IONM) in thyroidectomy performed for Graves’ disease (GD) with an emphasis on recurrent laryngeal nerve (RLN) management and completeness of resection. The study is a retrospective series comprising 55 thyroidectomy (control group) versus 82 procedures with intermittent IONM (I-IONM) and 72 by means of continuous IONM (C-IONM). In the control group the laryngeal nerves have been identified by visualization solely. In the I-IONM group both vagal nerve (VN) and RLN have been localized and monitored during thyroid resection. C-IONM was achieved with a vagal stimulation probe. I-IONM group had shorter operating times (P = 0.032). RLN morbidity, meaning palsy rate, was 2.7% in the C-IONM group, 3.6% in I-IONM and 5.4% in the control group (P = 0.058). The proportion of complete procedures (total or near total resections) were significantly higher using monitoring technology (P = 0.049). Persistent positive serum TBII values were found in 25 (45%), 25 (30%) and 20 (27%) patients at 12 months in the control, I-IONM and C-IONM groups respectively (P = 0,04). IONM is an effective technology in GD patients.

AB - We evaluate the role of intraoperative neuromonitoring (IONM) in thyroidectomy performed for Graves’ disease (GD) with an emphasis on recurrent laryngeal nerve (RLN) management and completeness of resection. The study is a retrospective series comprising 55 thyroidectomy (control group) versus 82 procedures with intermittent IONM (I-IONM) and 72 by means of continuous IONM (C-IONM). In the control group the laryngeal nerves have been identified by visualization solely. In the I-IONM group both vagal nerve (VN) and RLN have been localized and monitored during thyroid resection. C-IONM was achieved with a vagal stimulation probe. I-IONM group had shorter operating times (P = 0.032). RLN morbidity, meaning palsy rate, was 2.7% in the C-IONM group, 3.6% in I-IONM and 5.4% in the control group (P = 0.058). The proportion of complete procedures (total or near total resections) were significantly higher using monitoring technology (P = 0.049). Persistent positive serum TBII values were found in 25 (45%), 25 (30%) and 20 (27%) patients at 12 months in the control, I-IONM and C-IONM groups respectively (P = 0,04). IONM is an effective technology in GD patients.

KW - Graves’ disease

KW - Morbidity

KW - Neural monitoring

KW - Recurrent laryngeal nerve

KW - Thyroid surgery

UR - http://www.scopus.com/inward/record.url?scp=85056890843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056890843&partnerID=8YFLogxK

U2 - 10.1016/j.jcte.2018.11.002

DO - 10.1016/j.jcte.2018.11.002

M3 - Article

AN - SCOPUS:85056890843

VL - 15

SP - 6

EP - 11

JO - Journal of Clinical and Translational Endocrinology

JF - Journal of Clinical and Translational Endocrinology

SN - 2214-6237

ER -